Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Cellular and Molecular Biology 41: Tumor Suppressors 2

Novel role of human beta defensin-1 as a tumor suppressor that may be part of the innate immune system involved in tumor immunity

Rebecca S. Bullard, Jamila K. Belgrave, Willietta Gibson, Andre C. Eaddy, Corey J. Wright, Tomas A. Ganz, Janice M. Lage, Thomas E. Keane and Carlton D. Donald
Rebecca S. Bullard
Medical University of South Carolina, Charleston, SC and University of California at Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamila K. Belgrave
Medical University of South Carolina, Charleston, SC and University of California at Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willietta Gibson
Medical University of South Carolina, Charleston, SC and University of California at Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andre C. Eaddy
Medical University of South Carolina, Charleston, SC and University of California at Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corey J. Wright
Medical University of South Carolina, Charleston, SC and University of California at Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomas A. Ganz
Medical University of South Carolina, Charleston, SC and University of California at Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janice M. Lage
Medical University of South Carolina, Charleston, SC and University of California at Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas E. Keane
Medical University of South Carolina, Charleston, SC and University of California at Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlton D. Donald
Medical University of South Carolina, Charleston, SC and University of California at Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2005
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 46, 2005

Abstract

2891

Although it is known that innate immunity is key for protecting the body against foreign agents such as bacteria, little is known about elements of the innate immune system that have anti-tumoral activity. Defensins are small 3-4 kDa peptides clustered on the short arm of chromosome 8 (segment 8p22-8p23) that have been shown to have antimicrobial and antiviral activities. It has been demonstrated that there are chromosomal deletions in the 8pter-p23 regions in a variety of cancers including prostatic carcinoma. Additionally, there is a positive correlation between deletions in 8pter-p23 region and poor prognosis in prostate cancer. Furthermore, it has been postulated that there may be three separate potential tumor suppressor genes located in the 8pter-8p23 region. However, no specific gene has been identified that function in prostate cancer. Human β-defensin-1 (DEFB1) is located at chromosome position 8p23.2. We have previously demonstrated that there is cancer-specific loss of DEFB1 in malignant prostatic clinical samples, while high levels of expression are maintained in benign regions. Overall, 82% of prostate cancers exhibit either complete loss of DEFB1 protein expression or only minimal expression, while the adjacent benign epithelium retained expression in all cases. The high incidence of loss of DEFB1 expression in prostate cancer, along with its chromosomal location of 8p23.2, raised the possibility that it may be a tumor suppressor gene (TSG). To gain insight in its role in prostate cancer, DEFB1 was cloned into an inducible expression system to examine what effect it had on prostate cancer cell lines. In addition, DEFB1 expression levels were measured in prostatic tissue from patients that underwent radical prostatectomy to determine expression levels in benign tissue. The DEFB1 expression system was adjusted to produce DEFB1 protein in prostate cancer cells similar to those found in benign tissue. Induction of DEFB1 expression resulted in rapid morphological changes in both PC3 and DU145. In addition, there was a decrease in cellular growth and an accumulation of apoptotic and necrotic cells. Our findings suggest that DEFB1 may be a TSG and its loss may contribute to tumorigenesis in prostate cancer.

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 65 (9 Supplement)
May 2005
Volume 65, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Novel role of human beta defensin-1 as a tumor suppressor that may be part of the innate immune system involved in tumor immunity
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Novel role of human beta defensin-1 as a tumor suppressor that may be part of the innate immune system involved in tumor immunity
Rebecca S. Bullard, Jamila K. Belgrave, Willietta Gibson, Andre C. Eaddy, Corey J. Wright, Tomas A. Ganz, Janice M. Lage, Thomas E. Keane and Carlton D. Donald
Cancer Res May 1 2005 (65) (9 Supplement) 679;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Novel role of human beta defensin-1 as a tumor suppressor that may be part of the innate immune system involved in tumor immunity
Rebecca S. Bullard, Jamila K. Belgrave, Willietta Gibson, Andre C. Eaddy, Corey J. Wright, Tomas A. Ganz, Janice M. Lage, Thomas E. Keane and Carlton D. Donald
Cancer Res May 1 2005 (65) (9 Supplement) 679;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Identification and characterization of CAMSIT as a novel immunoglobulin-like cell adhesion molecule that exhibits growth inhibitory effect on human cancer cells
  • Cooperative effect of interaction between histone acetylation and GATA transcription factor on a tumor suppressor (DOC-2/DAB2) gene expression in bladder cancer cells
  • Knockdown of RASSF1A causes mitotic defects and tumor formation in nasopharyngeal epithelial cells
Show more Cellular and Molecular Biology 41: Tumor Suppressors 2
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement